# Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA

> **NCT03241719** · EARLY_PHASE1 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 2 (actual)

## Conditions studied

- Amputation, Traumatic
- Amputation;Traumatic;Old
- Face Injury
- Face; Deformity
- Abdominal Wall Defect

## Interventions

- **DRUG:** IL-2

## Key facts

- **NCT ID:** NCT03241719
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-17
- **Primary completion:** 2021-07-21
- **Final completion:** 2021-07-21
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** No participants are currently receiving therapy under this protocol, funding is coming to an end and the PI is leaving the institution.
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03241719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03241719, "Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03241719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*